Oversubscribed $15 million financing round led by Actium Group with participation from notable investors.
Organizations Involved
UT Southwestern Medical Center, Actium Group, Gates Foundation, Danaher Corporation, Eli Lilly and Company, American Cancer Society
Founders
RA Session II, Daniel J. Siegwart
Company Description
Signify Bio is a Dallas-based biotech company that harnesses the human body for the production of in situ protein therapeutics. The company offers modular platforms to engineer personalized protein therapeutics directly within the body, addressing challenges in drug production, delivery, and efficacy.
Market
Protein therapeutics
Location
Dallas,
Texas,
USA
Coinvestors
Gates Foundation Strategic Investment Fund, Danaher Ventures LLC, Eli Lilly and Company, BrightEdge